je.st
news
Tag: ebola
Ghana halts Ebola vaccine trial due to community protests
2015-06-11 05:43:32| Biotech - Topix.net
Ghana has halted a plan to test two Ebola vaccines in an eastern town after legislators backed local protests against the trials sparked by fears of contamination, officials said on Wednesday. The country's Food and Drugs Authority said it had begun enlisting volunteers in Hohoe in the Volta region to be injected with drugs made by Johnson & Johnson and Bavarian Nordic as part of a global Ebola vaccine drive.
Tags: community
due
trial
ghana
Man thought cured of Ebola wakes up with a green eye
2015-05-11 17:02:06| Extremetech
After a tough battle with Ebola, Ian Crozier's blood was finally cleared of the virus and his doctors thought he was cured. But when Ian woke one morning to find that his normally blue left had turned green, he knew something wasn't quite right.
Phase III Trial of the Merck and NewLink Genetics Investigational Ebola Vaccine Initiated in Sierra Leone
2015-04-14 19:30:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. & AMES, Iowa rVSV-ZEBOV-GP (V920) Now Being Studied in Three Key Safety and Efficacy Clinical Trials KENILWORTH, N.J. & AMES, Iowa--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and NewLink Genetics Corporation (NASDAQ: NLNK), confirmed today that the third, late-stage, clinical trial of their Ebola vaccine candidate rVSV-ZEBOV-GP (V920) has been initiated in Sierra Leone. The vaccine candidate was originally developed by the Public Health Agency of Canadas National Microbiology Laboratory and licensed to NewLink Genetics in 2010. On Nov. Language: English Contact: Merck Media:Pam Eisele, 267-305-3558orImraan Munshi, 215-652-0059Investor:NewLink Genetics:Jack Henneman, 515-598-2561orMerck:Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: NLNK Exchange: NASDAQ read more
Ebola, man with mask
2015-04-02 01:39:44| Biotech - Topix.net
Five Americans who were monitored for three weeks at an Omaha, Nebraska, hospital after being exposed to Ebola in West Africa have been released, a Nebraska Medicine spokesman said in an email Wednesday. One of the five had a heart-related issue on Saturday and has been discharged but hasn't left the area, Taylor Wilson wrote.
Two experimental Ebola vaccines pass safety test in African trial
2015-03-27 00:17:51| Biotech - Topix.net
Two experimental Ebola vaccines, one from GlaxoSmithKline PLC and the other from biotech start-up NewLink Genetics Corp, "appear to be safe" part way through a clinical trial being conducted in Liberia, the U.S. National Institutes of Health said on Thursday. The two vaccines, each given in a single injection, are being tested for safety and efficacy on more than 600 people in Liberia in a mid-stage clinical trial sponsored by the National Institute of Allergy and Infectious Diseases, a branch of NIH.
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] next »